Agency Information Collection Activities; Proposed Collection; Comments Requested: Application for Individual Manufacturing Quota for a Basic Class of Controlled Substance and for Ephedrine, Pseudoephedrine, and Phenylpropanolamine, 9428-9429 [2013-02876]

Agencies

• Drug Enforcement Administration
• Department of Justice

[Federal Register Volume 78, Number 27 (Friday, February 8, 2013)]
[Notices]
[Pages 9428-9429]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-02876]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[OMB Number 1117-0006]


Agency Information Collection Activities; Proposed Collection; 
Comments Requested: Application for Individual Manufacturing Quota for 
a Basic Class of Controlled Substance and for Ephedrine, 
Pseudoephedrine, and Phenylpropanolamine

ACTION: 30-day notice.

-----------------------------------------------------------------------

    The Department of Justice (DOJ), Drug Enforcement Administration 
(DEA) will be submitting the following information collection request 
to the Office of Management and Budget (OMB) for review and approval in 
accordance with the Paperwork Reduction Act of 1995. The proposed 
information collection is published to obtain comments from the public 
and affected agencies. This proposed information collection was 
previously published in the Federal Register Volume 77, Number 233, 
page 71831 on December 4, 2012, allowing for a 60 day comment period.
    The purpose of this notice is to allow for an additional 30 days 
for public comment until March 11, 2013. This process is conducted in 
accordance with 5 CFR 1320.10. Written comments and/or suggestions 
regarding the items contained in this notice, especially the estimated 
public burden and associated response time, should be directed to the 
Office of Management and Budget, Office of Information and Regulatory 
Affairs, Attention Department of Justice Desk Officer, Washington, DC 
20503. Additionally, comments may be submitted to OMB via facsimile to 
(202) 395-7285.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address one or more of the following 
four points:
     Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
     Evaluate the accuracy of the agencies estimate of the 
burden of the proposed collection of information, including the 
validity of the methodology and assumptions used;
     Enhance the quality, utility, and clarity of the 
information to be collected; and
     Minimize the burden of the collection of information on 
those who are to respond, including through the

[[Page 9429]]

use of appropriate automated, electronic, mechanical, or other 
technological collection techniques or other forms of information 
technology, e.g., permitting electronic submission of responses.

Overview of This Information Collection 1117-0006

    (1) Type of Information Collection: Extension of a currently 
approved collection.
    (2) Title of the Form/Collection: Application for Individual 
Manufacturing Quota for a Basic Class of Controlled Substance and for 
Ephedrine, Pseudoephedrine, and Phenylpropanolamine (DEA Form 189).
    (3) Agency form number, if any, and the applicable component of the 
Department of Justice sponsoring the collection: Form Number: DEA Form 
189, Office of Diversion Control, Drug Enforcement Administration, 
Department of Justice.
    (4) Affected public who will be asked or required to respond, as 
well as a brief abstract: Primary: Business or other for-profit.
    Other: None.
    Abstract: 21 U.S.C. 826 and 21 CFR 1303.22 and 1315.22 require that 
any person who is registered to manufacture any basic class of 
controlled substances listed in Schedule I or II and who desires to 
manufacture a quantity of such class, or who desires to manufacture 
using the List I chemicals ephedrine, pseudoephedrine, or 
phenylpropanolamine, must apply on DEA Form 189 for a manufacturing 
quota for such quantity of such class or List I chemical.
    (5) An estimate of the total number of respondents and the amount 
of time estimated for an average respondent to respond: DEA estimates 
that each form takes 0.5 hours (30 minutes) to complete. In total, 33 
firms submit 641 responses, with each response taking 0.5 hours (30 
minutes) to complete. This results in a total public burden of 320.5 
hours annually.
    (6) An estimate of the total public burden (in hours) associated 
with the collection: In total, 33 firms submit 641 responses, with each 
response taking 0.5 hours (30 minutes) to complete. This results in a 
total public burden of 320.5 hours annually.
    If additional information is required contact: Jerri Murray, 
Department Clearance Officer, Policy and Planning Staff, Justice 
Management Division, Department of Justice, Two Constitution Square, 
145 N Street, NE., Room 3W-1407B, Washington, DC 20530.

    Dated: February 5, 2013.
Jerri Murray,
Department Clearance Officer, PRA, United States Department of Justice.
[FR Doc. 2013-02876 Filed 2-7-13; 8:45 am]
BILLING CODE 4410-09-P